CRVS
#2350
Corvus Pharmaceuticals, Inc. - Common Stock
14.1 5 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.87%
Changement Mensuel
+5.91%
Evolution sur 6 mois
-19.14%
Changement Annuel
+161.07%
Clôture Précédente
14.7 2
Open
14.0 8
Low
14.0 7
High
14.1 9
Volume
80
Financials
- Market Capitalization 1.19 B
- Employee 37
- Founded 2014
- CEO N/A
- Website www.corvuspharma.com
- Headquarter Delaware, United States
- FIGI BBG009F0TGH8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-14.53
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2305 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 15.10 USD | -2.77% | -3.51% | -18.77% | +57.95% | 1.29 B USD | ||
| 2311 |  MNKD MannKind Corporation - Common Stock | 3.96 USD | -2.46% | -6.16% | +1.54% | -25.28% | 1.27 B USD | ||
| 2353 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.96 USD | -3.18% | +2.59% | +20.73% | +30.69% | 1.19 B USD | ||
| 2362 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.66 USD | -4.61% | -6.37% | -38.55% | +20.88% | 1.17 B USD |